Apex Ascension / Our point of view

What we believe
about raising capital.

A warm introduction can lead nowhere. A rejection can save you weeks. A calendar full of investor meetings can still leave your round without a lead.

These are the distinctions
we think matter.

Start here

All 23 beliefs

Who belongs in your raise

01 / 05

Warm isn’t the same as qualified.

A friendly introduction can get you a hearing. It can’t change a fund’s mandate, available capital, or check size. Before you count a warm conversation as progress toward the round, check whether the investor can actually take part. A good connection is worth having. It just isn’t the same thing as a qualified investor.

The introductionThey know you.

The questions that still matter

Your healthcare category?
Your stage and check size?
A role in this round?

A familiar name is a starting point. Not a fit check.

Your network isn’t the whole market.

The investors you know may share more than you think: geography, stage, sector, or the habit of following someone else’s lead. If they all pass, you’ve learned something about those conversations. Before calling it a market verdict, check who’s missing from your list. You haven’t tested the whole market just because you’ve exhausted your own contacts.

A good company can be wrong for a fund.

A device company might meet a healthcare investor who only backs software, or one who needs study results the round would pay to produce. Neither conversation settles the company’s worth. It does tell you whether this investor can finance this work. Find out whether you’re dealing with a mismatch or a real weakness in the business before you start changing things.

Your deadline isn’t their reason.

Running out of runway is a reason for your team to make decisions. It isn’t, by itself, a reason for an investor to invest. If the round funds a clinical study, explain what that study could establish and what would still be uncertain afterward. Show what the money would make possible, not just when you need it.

Explain the case for investing.

Don’t make an investor piece together the case for investing from a long explanation of the science. Say what’s changing, why the timing matters, and why your team can do the work. Then connect those answers to what this round would fund. You can make a clear case without pretending the outcome is certain.

What counts as progress

06 / 10

Three maybes don’t make a lead.

Three investors say they’ll consider following once a lead is in place. That’s useful to know, but you still need someone willing and able to lead. Another interested follower doesn’t fill that role, and a potential lead reviewing the deck hasn’t agreed to it. Track the missing commitment, not just the number of interested investors.

Investor A

“Who is leading?”

Investor B

“Once you have a lead.”

Investor C

“After a lead commits.”

One missing decision.Who is prepared to consider leading?

Three conversations. The same unresolved condition.

A useful no beats another maybe.

An investor who says they can’t invest before study results gives you something you can act on. Stop pursuing this round with them and consider returning after the readout. You don’t have to squeeze a lesson out of every rejection. But when someone names a real condition, write it down instead of keeping them on the list under ‘maybe’.

Write down what happened before interpreting it.

‘Requested the study budget’ is something that happened. ‘Interested in leading’ is your interpretation, unless the investor said so. Record the request, who made it, and any agreed next step. Keep your interpretation separate so someone reading the notes later can see what you know and what you’re still assuming.

What happened

“Send us the regulatory plan.”

What you know

They requested a document.
The funding decision is still open.

Keep the event. Be careful with the interpretation.

Look past the average.

A campaign can look unpromising overall while one investor group asks for diligence materials and another never gets past a polite reply. Look at each group’s response before changing the plan for everyone. A few conversations won’t settle which group is best, but they can show where to look more closely.

Silence doesn’t deserve unlimited follow-up.

A quiet inbox doesn’t tell you whether someone’s busy, unconvinced, or no longer looking at the opportunity. Follow up for a reason: an agreed action, a useful answer, or something material that changed. Decide when to pause. You can reopen the conversation when there’s something worth saying, but another unanswered email won’t explain the last one.

III

What deserves your attention

11 / 17

Better adjectives won’t fix missing evidence.

If an investor needs clinical results you don’t have, calling the device more groundbreaking won’t supply them. You may need a different investor, a different financing plan, or more evidence. First work out whether the case is hard to understand or not yet demonstrated. Better writing can make the argument clearer. It can’t make the missing evidence appear.

Check the channel before changing the story.

Before rewriting a story that gets no replies, check how it reached people. Did it reach the person you meant to contact, in a channel they use? A quiet inbox can be a delivery problem as well as a weak case. Check both before deciding what needs to change.

Change one thing at a time.

If you change the investor list, message, and outreach channel together, you won’t know which change helped. Pick one question to test and keep the rest as steady as you can. Write down what changed and what happened afterward. Small batches can guide the next test; they don’t prove you’ve found the answer.

Not every investor objection deserves a new deck.

One investor asks for a new market analysis. Before rebuilding the deck, ask whether the answer would help other investors or change a decision inside the company. Maybe the question exposes a real gap. Maybe this fund wants something your round can’t provide. Take the question seriously without letting every request jump to the front of the queue.

Leave room for the conversation.

The question an investor asks halfway through a call may matter more than your next slide. Know the argument well enough to step out of the slide order, answer plainly, and listen. Afterward, note what needed more explanation. Prepare for the next conversation around those questions, rather than just rehearsing the deck again.

One potential lead isn’t a reason to stop looking.

If a potential lead asks for the study budget, prepare it. You can also keep looking for other investors who could lead, in proportion to what’s still needed for the round. If this one passes, you won’t have to start from scratch. A promising conversation deserves attention, but it doesn’t fill the role.

Waiting should have a reason.

If you’re waiting for a scheduled investment review, record the date and decide what to do in the meantime. If there is no event or answer you’re waiting for, ask why the work has stopped. Pausing can be the right call. Make it a decision you can review, with a reason and a date.

What useful work leaves behind

18 / 23

Give help a specific job.

If investor research isn’t getting done, decide who’ll do it, what they’ll produce, and where they’ll need your judgment. That could be a teammate, an existing adviser, or someone new. Agree on what they’re responsible for and which decisions and relationships still need you. Adding a person doesn’t automatically mean the job is covered.

Investor information expires.

A fund that fit last year’s round may have a different team, less available capital, or a changed mandate today. Your company and financing needs may have changed too. Keep the source and date beside the information, then recheck what matters before you act. An old list can start the research. It shouldn’t finish it.

The relationship shouldn’t disappear when someone leaves.

A contact name and ‘positive call’ won’t tell the next person what was discussed, what’s still conditional, or what was promised. Keep enough shared context for a colleague to pick up the work without asking the investor to start over. You can’t simply transfer personal trust, but the conversation’s history shouldn’t leave the company when one person does.

The data room should support the deck.

If the deck says one thing and the financial model assumes another, an investor has to work out which to believe. Make it easy to follow a claim from the deck to the supporting documents. Use consistent figures, dates, and assumptions, and explain any differences. An orderly folder helps, but the contents still need to agree.

Keep the record when the round doesn’t close.

When a round doesn’t close, keep a record of what was tried, who responded, and which conditions stopped progress. Separate those findings from guesses about why it failed. That record may help you plan a later raise or decide not to pursue one yet. It won’t replace the capital you needed or erase what the attempt cost.

Give the board a decision, not a diary.

A list of meetings tells the board where the time went. It doesn’t explain what to do next. Show what’s changed, what’s still unresolved, and what you recommend doing about it. Name who’s responsible and when you’ll review it. You might continue, change course, or wait. Give the board a reason for that choice, not just a busy calendar.

The diary

~~We had twelve meetings.~~

The decision

Prepare the study budget one potential lead requested. Keep developing other plausible lead relationships.

What changed. What remains open. What happens next.

The point of all this

Less guessing.
Better decisions.

You don’t need to agree with every note. But your next investor conversation should leave you with a better question than “Did they like us?”

What we believe about raising capital.